Investing Profile

Kevin Bitterman

InvestorVC

Partner at ATLAS VENTURE

atlasventure.comCambridge, Massachusetts

Your Intro Paths to Kevin Bitterman

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Kevin Bitterman on

Current Investing Position

Investment Range

$10.0M - $50.0M

Sweet Spot

$25.0M

Investments On Record

Kevin Bitterman is on these Sector & Stage Rankings

Kevin Bitterman's Investments On Record (18)

Company	StageDateRound Size	Total Raised
Renasant Bio	SeedJul 2025$55M	$55M
Co-investors: Deborah Palestrant (5am Ventures)
Judo Bio	Series AOct 2024$75M SeedNov 2023$25M	$100M
Co-investors: Samuel Bjork (Digitalis Ventures), Steven Robinette (Atlas Venture)
GRO Biosciences	Series BJul 2024$60M	$91M
Co-investors: Ameena El-Bibany (Artis Ventures (AV)), Russ Wilcox (Pillar VC), Geoffrey Smith (Digitalis Ventures), Dror Berman (Innovation Endeavors)
Disc Medicine	Post Ipo EquityJun 2024$180M Series AOct 2019$50M	$440M
Co-investors: Mona Ashiya (OrbiMed Advisors)
Remix Therapeutics	Series UnknownJan 2024$60M Series BMay 2022$70M Series ADec 2020$65M SeedJan 2019$16M	$210M
Co-investors: Leon Chen (The Column Group), Kristina Burow (ARCH Venture Partners), Michael Rome (Foresite Capital), Peter Svennilson (The Column Group)
Mariana Oncology	Series BSep 2023$180M Series ADec 2021$75M	$250M
Co-investors: Geert-Jan Mulder (Forbion), Josh Resnick
Curie Therapeutics	Series ADec 2021$75M	$75M
Akero Therapeutics	Series BDec 2018$70M Series AJun 2018$65M	$140M
Co-investors: Aaron Royston (venBio)